Turkish journal of urology最新文献

{"title":"Artificial Urinary Sphincter in a High-Risk Urethra: Transcorporal Gullwing Modification Description of the Technique.","authors":"David Hernández-Hernández,&nbsp;María Yanira Ortega-González,&nbsp;Bárbara Padilla-Fernández,&nbsp;David Manuel Castro-Díaz","doi":"10.5152/tud.2022.22134","DOIUrl":"https://doi.org/10.5152/tud.2022.22134","url":null,"abstract":"<p><strong>Background: </strong>In this report, we describe a modification of transcorporal artificial urinary sphincter place ment known as Gullwing modification.</p><p><strong>Description of technique: </strong>Using a penoscrotal approach, bilateral corpora cavernosa flaps are harvested and sutured in the midline covering the lateral and ventral surfaces of the urethra. Transcorporal cuff placement provides dorsal reinforcement, thus having extra tissue buttressing all the circumference in cases of a fragile urethra due to previous urethral cuff erosion, urethroplasty, or pelvic radiotherapy.</p><p><strong>Patient and methods: </strong>After previous urethral cuff erosion, radiotherapy, and urethral reconstruction, our patient complained of severe stress urinary incontinence. Due to the high risk of urethral complications, we proceed to a transcorporal artificial sphincter placement with urethral reinforcement through a bilateral cavernosal flap.</p><p><strong>Results: </strong>The surgery was successfully completed, and after 6 weeks, sphincter was activated with satisfac tory results. Two years after surgery, his continence status is stable without complications.</p><p><strong>Conclusion: </strong>Urethral complications associated with artificial urinary sphincter surgery remain a challenge for the reconstructive surgeon. Reinforcement of the ventral aspect of the urethra through corpora cavernosal flaps may reduce the likelihood of urethral erosion in high-risk cases.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"460-464"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797734/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AHNAK2 Urinary Protein Expression as Potential Biomarker for Bladder Cancer Detection: A Pilot Study.","authors":"Selim Komina,&nbsp;Gordana Petrusevska,&nbsp;Rubens Jovanovic,&nbsp;Slavica Kostadinova Kunovska,&nbsp;Sotir Stavridis,&nbsp;Saso Dohcev,&nbsp;Skender Saidi,&nbsp;Sonja Topuzovska","doi":"10.5152/tud.2022.22132","DOIUrl":"https://doi.org/10.5152/tud.2022.22132","url":null,"abstract":"Objective: This study aimed to measure the AHNAK2 urinary levels in bladder cancer patients. Material and methods: This prospective case–control study enrolled 67 participants between January and March 2019 and were categorized into bladder cancer group (n = 37), with histologically proven bladder cancer, and control group (n = 30), with histologically verified benign lesions or with no bladder cancer indication during follow-up. Urine samples of 15 mL were collected in the mid-morning before cystoscopy/surgery and an enzyme-linked immunosorbent assay was performed as per the manufacturer’s protocol. Bladder malignancies were classified according to the World Health Organization Tumor Classification. Group’s associations were evaluated with the Student t-test, Spearman’s rank correlation, and Mann–Whitney U test, while receiver operating curve was plotted for assessing the test’s performance. Results: Mean age of the bladder cancer group was 66.41 years (standard deviation = 10.04, range = 43-82 years) and the control group was 59.67 years (standard deviation = 10.44, range = 38-77 years). All bladder cancers were of the urothelial histotype, with the following pT distribution: pTa/papillary urothelial neoplasm of low malignant potential (n = 19; 28.4%), Primary tumor (pT) in situ (n = 4; 6%), pT1 (n = 7; 10.4%), and pT≥2 (n = 7; 10.48%). Mean AHNAK2 levels were higher in bladder cancer patients 49.08 pg/mL (standard deviation = 114.91) compared to controls 5.28 pg/mL (standard deviation = 6.65), P < .05). Significant differences were noted between non-invasive bladder cancer (n = 23; mean = 7.14 pg/mL; standard deviation = 7.26) and invasive bladder cancer (n = 14; mean = 117.99 pg/mL; standard deviation = 168.08) and between non-muscle invasive bladder cancer (mean = 23.19 pg/mL; standard deviation = 66.93) and muscle-invasive bladder cancer (mean = 160.05 pg/mL; standard deviation = 199.65) (P < .001). The result of the assays was given as follows: sensitivity: 64.19%, specificity: 66.67%, positive predictive value: 22.07%, negative predictive value: 92.37%, area under curve: 0.695, and 95% CI: 0.57-0.82. Conclusion: AHNAK2 protein could be used as bladder cancer surveillance biomarker. The inclusion of AHNAK2 levels in stratification nomograms might reduce the number of unnecessary cystoscopies.","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"423-430"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Evaluation of the First Bahname Written in Turkish in the Ottoman Era Concerning Current Urology.","authors":"Muhammet Ihsan Karaman, Adem Az","doi":"10.5152/tud.2022.22104","DOIUrl":"10.5152/tud.2022.22104","url":null,"abstract":"<p><strong>Objective: </strong>Our study investigated the oldest known Turkish bahname, translated by Musa b. Mes'ud, in comparison with the current literature.</p><p><strong>Material and methods: </strong>First, the original manuscript of the translation was transcribed in Latin. The final version of the text was analyzed in the results. In discussion, findings were examined and interpreted within the framework of current knowledge of sexology, urology, and andrology.</p><p><strong>Results: </strong>Although the work mostly mentions supportive and therapeutic practices in sexual health, it also provides advice on sexuality and sexual life, discussing several topics regarding sexual intercourse types, explaining which ones are good or harmful, and their timing or frequency. The author recommends many foods and compounds or specific drugs and ointments to enhance sexual stamina and avoid erectile dysfunc tion. In addition, he also tries to find solutions to some other sexual health problems related to men and women. These issues are generally evaluated in the context of health; a religious perspective is also provided when needed.</p><p><strong>Conclusion: </strong>Interestingly, the author's recommendations on sexual health and herbal or animal drugs are consistent with the current literature. Nevertheless, some information and suggestions in works are entirely irrational and unscientific. Consequently, this study is an original investigation of the first translated bahname into Turkish. There is no other study examining the bahnames with this method. Thus, we believe that our work will be a significant contribution to the research literature.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"446-454"},"PeriodicalIF":1.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Revision Labiaplasty After Penile Inversion Vaginoplasty Using Costal Cartilage Allograft.","authors":"Nicholas Sellke,&nbsp;Michael Callegari,&nbsp;Kirtishri Mishra,&nbsp;Tobias Long,&nbsp;Shubham Gupta","doi":"10.5152/tud.2022.22079","DOIUrl":"https://doi.org/10.5152/tud.2022.22079","url":null,"abstract":"<p><strong>Background: </strong>Gender-affirming surgery leads to high satisfaction for patients; however, patients often require revision surgery. Revision labiaplasty is one of the most common surgeries following vaginoplasty. The labia minora commonly become incorporated into the labia majora and lose definition even after revision leading to patient dissatisfaction.</p><p><strong>Description of technique: </strong>We propose a technique of incorporating cadaveric costal cartilage allograft into the revised labia minora to increase the definition.</p><p><strong>Patient and methods: </strong>The procedure was demonstrated in a 38-year-old MTF patient who had previously undergone inversion vaginoplasty. The cartilage allograft was incorporated within the labia minora flaps dur ing labiaplasty.</p><p><strong>Results: </strong>The patient had lasting definition of her labia minora post-operatively at 6 weeks without adverse effects.</p><p><strong>Conclusion: </strong>We believe that this technique may be effective and safe in patients requesting more defined labia minora after vaginoplasty.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"455-459"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797741/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intestinal Microbiota Correction in the Treatment and Prevention of Urinary Tract Infection.","authors":"Nikolay V Sturov,&nbsp;Sergey V Popov,&nbsp;Vladimir A Zhukov,&nbsp;Tatiana V Lyapunova,&nbsp;Ekaterina I Rusanova,&nbsp;Georgy N Kobylyanu","doi":"10.5152/tud.2022.22119","DOIUrl":"https://doi.org/10.5152/tud.2022.22119","url":null,"abstract":"<p><p>Intestinal microbiota is a topical subject of modern research. The maintenance of a healthy intestinal micro biota is an important component of homeostasis, and violations of its composition and functions, called dysbiosis, are associated with a number of diseases, including urinary tract infections. Antimicrobial therapy leads to significant changes in the intestinal microbiota and causes the possibility of urinary tract infection recurrence. In this regard, it is important to study methods of microbiota correction in order to restore its structural and functional integrity.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"406-414"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Initial Experience of Hybrid Technique in Robot-Assisted Intracorporeal Ileal Conduit.","authors":"Shugo Yajima,&nbsp;Yasukazu Nakanishi,&nbsp;Yousuke Umino,&nbsp;Naoya Ookubo,&nbsp;Kenji Tanabe,&nbsp;Madoka Kataoka,&nbsp;Hitoshi Masuda","doi":"10.5152/tud.2022.22125","DOIUrl":"https://doi.org/10.5152/tud.2022.22125","url":null,"abstract":"<p><strong>Objective: </strong>This study was designed to describe our hybrid approach to intracorporeal urinary diversion and evaluate surgical experience during initial induction.</p><p><strong>Material and methods: </strong>Clinical data from 38 patients with bladder cancer undergoing robot-assisted radical cystectomy with ileal conduit hybrid approach to intracorporeal urinary diversion at our institution between May 2020 and January 2022 were reviewed. The hybrid approach to intracorporeal urinary diversion pro cedure involved the following: radical cystectomy, removing a specimen through a 4- to 6-cm skin incision, harvesting an ileal conduit, redocking the robot, and uretero-uretero anastomosis. The relationship between surgical experience and operative time and a Clavien-Dindo classification of grade >3 was evaluated.</p><p><strong>Results: </strong>Of the 38 patients, 30 (79%) were male, and the median age was 75 years (interquartile range, 71-80 years). The total operative time was 384 minutes (interquartile range, 348-409 minutes). The estimated blood loss was 244 mL (interquartile range, 124-445 mL). No bowel injuries or conversions to laparoscopy or laparotomy were encountered. High-grade postoperative complications (Clavien-Dindo classification grade > 3) occurred in 7 cases (19%). The overall 90-day readmission rate following discharge after surgery was 5%. The relationship between surgical experience and operative time was nonlinear. A plateau was not reached in all 38 patients.</p><p><strong>Conclusion: </strong>Our hybrid approach to intracorporeal urinary diversion technique can be accomplished safely with acceptable operative times, even with little surgical experience. This procedure might be a safe treat ment option that is relatively easy to perform, particularly in an institution that has not yet introduced intra corporeal urinary diversion. Future randomized trials with larger samples and longer follow-up periods are required to confirm our findings.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"415-422"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biopsy with Ureterorenoscopy Before Radical Nephroureterectomy is Associated with Increased Intravesical Recurrence in Urothelial Cancer Located in the Kidney.","authors":"Meftun Culpan,&nbsp;Mehmet Caglar Cakici,&nbsp;Ferhat Keser,&nbsp;Mehmet Yigit Yalcin,&nbsp;Taner Kargi,&nbsp;Rıdvan Kayar,&nbsp;Erdal Abay,&nbsp;Gorkem Ozenc,&nbsp;Ali Kumcu,&nbsp;Mehmet Pehlivanoglu,&nbsp;Semih Turk,&nbsp;Erdem Kisa,&nbsp;Selcuk Sahin,&nbsp;Metin Ishak Ozturk,&nbsp;Alper Otunctemur,&nbsp;Resul Sobay,&nbsp;Huseyin Cihan Demirel,&nbsp;Omer Yilmaz,&nbsp;Gokhan Atis,&nbsp;Muhammet Abdurrahim Imamoglu,&nbsp;Asif Yildirim","doi":"10.5152/tud.2022.22143","DOIUrl":"https://doi.org/10.5152/tud.2022.22143","url":null,"abstract":"<p><strong>Objective: </strong>Diagnostic ureterorenoscopy is used to identify upper tract urothelial cancer before radical nephro ureterectomy, especially for uncertain lesions in imaging modalities or urine cytology. However, diagnostic ureterorenoscopy can potentially cause intravesical tumor spillage and can increase intravesical recurrence rates. We aimed to investigate the impact of diagnostic ureterorenoscopy before radical nephroureterectomy, with and without biopsy, on intravesical recurrence rates of patients with upper tract urothelial cancer.</p><p><strong>Material and methods: </strong>Patients with localized upper tract urothelial cancer from 8 different tertiary referral centers, who underwent radical nephroureterectomy between 2001 and 2020, were included. Three groups were made: no URS (group 1); diagnostic ureterorenoscopy without biopsy (group 2); and diagnostic ure terorenoscopy with biopsy (group 3). Intravesical recurrence rates and survival outcomes were compared. Univariate and multivariate Cox regression analyses were performed to determine the factors that were asso ciated with intravesical recurrence-free survival.</p><p><strong>Results: </strong>Twenty-two (20.8%), 10 (24.4%), and 23 (39%) patients experienced intravesical recurrence in groups 1, 2, and 3, respectively (P=.037) among 206 patients. The 2-year intravesical recurrence-free sur vival rate was 83.1%, 82.4%, and 69.2%, for groups 1, 2, and 3, respectively (P=.004). Cancer-specific survival and overall survival were comparable (P=.560 and P=.803, respectively). Diagnostic ureterore noscopy+biopsy (hazard ratio: 6.88, 95% CI: 2.41-19.65, P < .001) was the only independent predictor of intravesical recurrence in patients with upper tract urothelial cancer located in the kidney, according to tumor location.</p><p><strong>Conclusion: </strong>Diagnostic ureterorenoscopy+biopsy before radical nephroureterectomy significantly increased the rates of intravesical recurrence in tumors located in kidney. This result suggests tumor spillage with this type of biopsy, so further studies with different biopsy options or without biopsy can be designed.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"431-439"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Novel Algorithm for the Management of Hematospermia.","authors":"Ozan Efesoy,&nbsp;Selahittin Çayan,&nbsp;Erdem Akbay","doi":"10.5152/tud.2020.20428","DOIUrl":"https://doi.org/10.5152/tud.2020.20428","url":null,"abstract":"<p><p>Hematospermia or hemospermia is traditionally defined as the presence of fresh or altered blood in semen. Several factors might cause hematospermia, including infectious, inflammatory, iatrogenic, traumatic, structural, neoplastic, vascular, and systemic factors. The main aim of evaluation is to identify significant or treatable underlying causes of hematospermia and to re-assure the patient if no causative factor is detected after full evaluation. This review aims novel management of hematospermia, including a detailed history, physical examination, appropriate laboratory investigations, and diagnostic imaging, based on underlying causes of hematospermia.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":" ","pages":"398-405"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38535031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advances in Penile Prosthesis Surgery: A Clinical Update.","authors":"Ömer Onur Çakır,&nbsp;Wai Gin Lee,&nbsp;Philippa Ralph,&nbsp;Mathew Megson,&nbsp;David J Ralph","doi":"10.5152/tud.2020.20442","DOIUrl":"https://doi.org/10.5152/tud.2020.20442","url":null,"abstract":"<p><p>Despite the introduction of effective oral pharmacotherapy for the treatment of erectile dysfunction (ED), penile implants are still the standard care for patients who do not respond well to medical therapy. Since the first inflatable penile implant surgery was performed almost 40 years ago, a variety of improvements in the penile prosthesis design, and advancements in material science, surgical technique, and post-operative care have been developed to increase patients' satisfaction, as well as that of their partners. Penile implants have evolved vastly during that same time frame and now represent the cutting-edge technology, durability, and function. Here, advancements are reviewed with a focus upon recent developments in surgical techniques and device technology.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":" ","pages":"393-397"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38535033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Review of 175 Cases of Tuberculosis Infections Affecting the Urogenital System.","authors":"Nuno Dias,&nbsp;Teresa Pina-Vaz,&nbsp;Pedro Abreu-Mendes,&nbsp;Tiago Azeredo-Costa,&nbsp;Pedro Rodrigues-Pereira,&nbsp;Carlos Silva,&nbsp;Francisco Botelho","doi":"10.5152/tud.2022.22148","DOIUrl":"https://doi.org/10.5152/tud.2022.22148","url":null,"abstract":"<p><strong>Objective: </strong>Urogenital tuberculosis and disseminated tuberculosis affecting urogenital system are more fre quent in developing countries but are often overlooked in developed ones. We aimed to compare clinical characteristics and outcomes of urogenital tuberculosis and disseminated tuberculosis affecting the urogeni tal system.</p><p><strong>Material and methods: </strong>We retrospectively reviewed data from patients with tuberculosis in the urogenital system, diagnosed in a tertiary center in a European country, from 2008 to 2018. Cases were divided into urogenital tuberculosis and disseminated tuberculosis affecting the urogenital system and compared.</p><p><strong>Results: </strong>We included 172 patients, 31 with urogenital tuberculosis and 141 with disseminated tuberculosis affecting urogenital system. Patients with disseminated tuberculosis affecting the urogenital system were younger (median 45 vs. 64 years, P=.001), more likely to be male (80 vs. 55%, P=.005), or having risk fac tors for the disease (84 vs. 23%, P=.005) than patients with urogenital tuberculosis. Patients with urogenital tuberculosis presented most commonly with symptoms related to the urinary tract, with 52% complaining of lower urinary tract symptoms attributed to urinary tract infections and 48% of dysuria, while patients with disseminated tuberculosis affecting the urogenital system presented mainly with systemic symptoms, with 89% complaining of malaise, 62% of fever, and 57% of anorexia. Patients with urogenital tuberculosis were more likely to need urological surgery as part of their treatment (71 vs. 5%, P < .001) and patients with dis seminated tuberculosis affecting the urogenital system were more likely to die due to tuberculosis (10 vs. 21%, P < .001).</p><p><strong>Conclusion: </strong>Tuberculosis of the urogenital system can have multiple clinical presentations, and a simple diagnostic algorithm does not exist. In the presence of urogenital tuberculosis in injected drug users, immu nosuppressed individuals, or patients with systemic symptoms, we should think of disseminated tuberculosis affecting the urogenital system and remember these patients less frequently need surgery but entail a worst outcome.</p>","PeriodicalId":23366,"journal":{"name":"Turkish journal of urology","volume":"48 6","pages":"440-445"},"PeriodicalIF":1.3,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797796/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10818558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}